Status:
COMPLETED
Angio-Seal Evolution Device Registry
Lead Sponsor:
Abbott Medical Devices
Conditions:
Peripheral Vascular Disease
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Collect data on the use of the Angio-Seal Evolution Device in diagnostic and interventional patient populations.
Detailed Description
This multi-center clinical registry is designed to collect data on the use of the Angio-Seal Evolution Device in patients who have had diagnostic and/or interventional procedures through femoral arter...
Eligibility Criteria
Inclusion
- Patient is having a diagnostic and/or interventional procedure via femoral artery access.
Exclusion
- Patients who are unable to provide written informed consent.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
1004 Patients enrolled
Trial Details
Trial ID
NCT00817349
Start Date
July 1 2008
End Date
April 1 2010
Last Update
February 4 2019
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Good Samaritan Hospital
Los Angeles, California, United States, 90017
2
Michigan Heart, P.C.
Ypsilanti, Michigan, United States, 48197
3
Cooper Health System
Camden, New Jersey, United States, 08103
4
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States, 27157